Skip to content
Screener

Medifast MED Q1 2025 earnings

Reported April 28, 2025 · After market close

Revenue$115.7MBeat by $19.6M
EPS-$0.11Miss by $0.04
Revenue estimate$96.1M
EPS estimate-$0.07

Next report

Nov 9, 2026 (in 2 months)
Revenue estimate$71.3M
EPS estimate-$0.35

Financials

Q1 2025

Income statement

See full
Revenue$115.7M-33.8%
Gross profit$84.2M-33.8%
Operating income-$1.3M-116%
Net income-$772.0K-109%
EPS (diluted)-$0.07-109%

Balance sheet

See full
Cash & equivalents$91.7M-5.9%
Total debt$14.6M-29.0%
Total equity$211.0M0.0%
Total assets$280.0M-7.5%

Cash flow

See full
Operating cash flow$3.4M-53.2%
CapEx$1.5M-17.3%
Free cash flow$1.9M-65.4%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$147.44M-64.7%
Enterprise value$70.33M-79.4%
P/S0.3×-0.2×

Profitability

See full
Gross margin73.9%+0.7pp
Operating margin-1.2%-10.2pp
Net margin-1.3%-8.8pp

Returns & leverage

See full
Return on equity-3.3%-38.8pp
Debt / equity0.1×0.0×
Current ratio3.5×+0.7×

Segments

By segment

See full
Optavia Segment$115.7M-33.8%

FAQ

When did Medifast report Q1 2025 earnings?
Medifast (MED) reported Q1 2025 earnings on April 28, 2025 after market close.
What were Medifast's Q1 2025 revenue and EPS?
Medifast reported revenue of $115.7M and eps of $-0.11 for Q1 2025.
Did Medifast beat estimates in Q1 2025?
Revenue beat the consensus estimate of $96.1M by $19.6M. EPS missed the consensus estimate of $-0.07 by $0.04.
How did Medifast's Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 33.8% from $174.7M a year earlier.
Where can I find Medifast's Q1 2025 SEC filings?
You can read the 8-K earnings release (0001628280-25-020336) and the 10-Q periodic report (0001628280-25-020341) directly on SEC EDGAR. The filing index links above go to sec.gov.